Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
November 14, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility.
Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over Age 50
July 09, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray-led scientific publication examines the real-world impact of medical cannabis use on patients over the age of 50.
Tilray Medical Launches Broken Coast Medical Cannabis Brand in Australia
June 20, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray's Broken Coast EU-GMP Certified Medical Cannabis Whole Flower Products Are Now Available through a Doctor’s Prescription in Australia